Utah Medical Products Stock Today
| UTMD Stock | USD 67.56 0.57 0.84% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Utah Medical is trading at 67.56 as of the 24th of April 2024, a -0.84 percent decrease since the beginning of the trading day. The stock's lowest day price was 67.46. Utah Medical has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Utah Medical Products are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 8th of March 1999 | Category Healthcare | Classification Health Care |
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company was incorporated in 1978 and is headquartered in Midvale, Utah. Utah Medical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. The company has 3.59 M outstanding shares of which 55.34 K shares are at this time shorted by private and institutional investors with about 1.44 trading days to cover. More on Utah Medical Products
Moving against Utah Stock
| 0.77 | AGTI | Agiliti Sell-off Trend | PairCorr |
| 0.77 | VKTX | Viking Therapeutics Earnings Call Today | PairCorr |
| 0.75 | HQY | HealthEquity Financial Report 3rd of June 2024 | PairCorr |
| 0.7 | THMO | Thermogenesis Holdings Financial Report 20th of May 2024 | PairCorr |
| 0.7 | ELEV | Elevation Oncology Financial Report 20th of May 2024 | PairCorr |
| 0.69 | RCM | R1 RCM Inc Financial Report 2nd of May 2024 | PairCorr |
| 0.62 | DSGN | Design Therapeutics Downward Rally | PairCorr |
Utah Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Utah Medical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Utah Medical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Kevin Cornwell | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation Analysts covering Utah Medical report their recommendations after researching Utah Medical's financial statements, talking to executives and customers, or listening in on Utah Medical's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Utah Medical Products. The Utah consensus assessment is calculated by taking the average forecast from all of the analysts covering Utah Medical. | |||||
Utah Medical's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Utah Medical's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Utah Medical's financial leverage. It provides some insight into what part of Utah Medical's total assets is financed by creditors.
| |||||
Utah Medical Products (UTMD) is traded on NASDAQ Exchange in USA. It is located in 7043 South 300 West, Midvale, UT, United States, 84047-1048 and employs 169 people. Utah Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 242.47 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Utah Medical's market, we take the total number of its shares issued and multiply it by Utah Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Utah Medical Products conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 3.59 M outstanding shares of which 55.34 K shares are at this time shorted by private and institutional investors with about 1.44 trading days to cover.
Utah Medical Products currently holds about 69.51 M in cash with 22.28 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 19.17.
Check Utah Medical Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Utah Medical is $242.47 Million. The majority of Utah Medical Products outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Utah Medical to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Utah Medical Products. Please pay attention to any change in the institutional holdings of Utah Medical Products as this could imply that something significant has changed or is about to change at the company. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the company is less than the current market value, you may not be able generate positive returns on investment in the long run.
Check Utah Ownership Details
Utah Stock Price Odds Analysis
What are Utah Medical's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Utah Medical jumping above the current price in 90 days from now is about 83.8%. The Utah Medical Products probability density function shows the probability of Utah Medical stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.1195. This usually implies Utah Medical Products market returns are highly-sensitive to returns on the market. As the market goes up or down, Utah Medical is expected to follow. Additionally, utah Medical Products has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Utah Medical to move above the current price in 90 days from now is about 83.8 (This Utah Medical Products probability density function shows the probability of Utah Stock to fall within a particular range of prices over 90 days) .
Utah Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Utah Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Utah Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Utah Medical's value.| Instituion | Recorded On | Shares | |
| Jpmorgan Chase & Co | 2023-12-31 | 63.6 K | |
| Penn Mutual Asset Management Llc | 2023-12-31 | 53.1 K | |
| Loomis, Sayles & Company Lp | 2023-12-31 | 44.4 K | |
| Franklin Resources Inc | 2023-12-31 | 43.3 K | |
| Northern Trust Corp | 2023-12-31 | 38.6 K | |
| Bank Of New York Mellon Corp | 2023-12-31 | 36.5 K | |
| Brandes Investment Partners & Co | 2023-12-31 | 32.8 K | |
| Clean Yield Group Inc | 2023-12-31 | 31.7 K | |
| Isthmus Partners Llc | 2023-12-31 | 22.7 K | |
| Fmr Inc | 2023-12-31 | 389.7 K | |
| T. Rowe Price Investment Management,inc. | 2023-12-31 | 269.2 K |
Utah Medical Historical Income Statement
Utah Medical Products Income Statement is one of the three primary financial statements used for reporting Utah's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Utah Medical Products revenue and expense. Utah Medical Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Utah Medical's Total Operating Expenses is projected to increase significantly based on the last few years of reporting. The current year's Income Tax Expense is expected to grow to about 3.8 M, whereas Total Revenue is forecasted to decline to about 36.6 M. View More FundamentalsUtah Stock Against Markets
Picking the right benchmark for Utah Medical stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Utah Medical stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Utah Medical is critical whether you are bullish or bearish towards Utah Medical Products at a given time. Please also check how Utah Medical's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Utah Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
| All Next | Launch Module |
Utah Medical Corporate Directors
Utah Medical corporate directors refer to members of an Utah Medical board of directors. The board of directors generally takes responsibility for the Utah Medical's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Utah Medical's board members must vote for the resolution. The Utah Medical board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Ernst Hoyer | Lead Independent Director | Profile | |
| Paul Richins | Principal Financial Officer, Chief Admin. Officer, VP, Treasurer, Assistant Secretary and Director | Profile | |
| Barbara Payne | Independent Director | Profile | |
| James Beeson | Independent Director | Profile |
How to buy Utah Stock?
Before investing in Utah Medical, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Utah Medical. To buy Utah Medical stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Utah Medical. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Utah Medical stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Utah Medical Products stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Utah Medical Products stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Utah Medical Products, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Utah Stock please use our How to Invest in Utah Medical guide.
Already Invested in Utah Medical Products?
The danger of trading Utah Medical Products is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Utah Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Utah Medical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Utah Medical Products is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Utah Stock analysis
When running Utah Medical's price analysis, check to measure Utah Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Utah Medical is operating at the current time. Most of Utah Medical's value examination focuses on studying past and present price action to predict the probability of Utah Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Utah Medical's price. Additionally, you may evaluate how the addition of Utah Medical to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |
Is Utah Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Dividend Share 1.185 | Earnings Share 4.57 | Revenue Per Share 13.84 | Quarterly Revenue Growth (0.09) |
The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Utah Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.